TM Editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.Company: Galapagos NVBloomberg ticker: GLPG NAMarket cap: US$2,722mBackground: Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action, with a pipeline comprising Phase 3, 2, 1, pre-clinical and discovery studies in cystic fibrosis, inflammation, fibrosis, osteoarthritis, and other indications.
World Class Benchmarking of Galapagos NV 
More By This Author:Asian Stock: Hualan Biological Engineering
Asian Stock: Run Long Construction
US Stock: Oshkosh
